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ABSTRACT 
Aim: This study evaluated the clinical value of myocardial contrast delayed enhancement 
(DE) with multidetector computed tomography (MDCT) for detecting microvascular 
obstruction (MVO) and left ventricular (LV) remodeling revealed by DE magnetic resonance 
imaging (DE-MRI) after acute myocardial infarction (AMI). 
Methods and Results: In 92 patients with first AMI, MDCT without iodine reinjection was 
performed immediately following successful percutaneous coronary intervention (PCI). 
DE-MRI performed in the acute and chronic phases was used to detect MVO and LV 
remodeling (any increase in LV end-systolic volume at 6 months after infarction compared 
with baseline). Patients were divided into 2 groups according to the presence (n=33) or 
absence (n=59) of heterogeneous enhancement. Heterogeneous enhancement was defined as 
concomitant presence of hyper- and hypoenhancement within the infarcted myocardium on 
MDCT. MVO and LV remodeling were detected in 49 (53%) and 29 (32%) patients, 
respectively. In a multivariate analysis, heterogeneous enhancement and a relative CT density 
>2.20 were significant independent predictors for MVO (odds ratio [OR] 13.5; 95% 
confidence interval [CI], 2.15-84.9; P=0.005 and OR 12.0; 95% CI, 2.94-49.2; P<0.001, 
respectively). The presence of heterogeneous enhancement and relative CT density >2.20 
showed a high PPV of 93%, and absence of these two findings yielded a high NPV of 90% 
for the predictive value of MVO. Heterogeneous enhancement was significantly associated 
4 
 
with LV remodeling (OR 3.97; 95% CI, 1.26-12.60; P=0.019). 
Conclusions: Heterogeneous enhancement detected by MDCT immediately after primary 
PCI may provide promising information for predicting MVO and LV remodeling in patients 
with AMI. 
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Introduction 
Primary percutaneous coronary intervention (PCI) has improved the prognosis of patients 
with acute myocardial infarction (AMI).1,2 However, despite successful recanalization of the 
culprit vessel, left ventricular (LV) remodeling occurs in an appreciable proportion of 
patients with AMI.3 LV remodeling following AMI is a major predictor of morbidity and 
mortality for overt congestive heart failure and life-threatening arrhythmias.4 LV remodeling 
is predicted by the extent of transmurality and infarct size after AMI.5 Late 
gadolinium-enhanced cardiac magnetic resonance imaging (MRI) is the current clinical 
standard for the assessment of LV infarct size,6 microvascular obstruction (MVO),7 and the 
prediction of functional recovery.8 
Myocardial delayed enhancement (DE) on multidetector computed tomography (MDCT) 
enables the accurate evaluation of infarct size9 and has comparable results as an alternative 
technique to MRI in AMI.10,11 Myocardial DE on MDCT allows the early evaluation of 
myocardial viability immediately after PCI without additional injection of contrast agent.12 In 
our previous study, we showed that contrast DE patterns might be reliably useful in 
predicting functional recovery of the post-ischemic myocardium and LV remodeling,13 and 
myocardial contrast DE size might be a very early predictive marker for future clinical 
cardiac events in patients with AMI.14 Recently, Amanieu et al. reported that the presence of 
a hypoenhanced area had high specificity for the prediction of MVO.15 MVO, which is an 
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area of hypoenhancement surrounding hyperenhancement detected by DE-MRI, corresponds 
to the production of no-reflow regions and reflects myocardial microvascular dysfunction.16 
Furthermore, the extent of MVO has been shown to determine the magnitude of myocardial 
damage, and it provides an incremental prognostic marker of functional recovery and 
prognosis beyond that of infarct size.5,7,17 Therefore, we hypothesized that the presence of 
hypoenhanced areas detected on DE-MDCT in AMI patients may have a similar potential to 
predict LV remodeling. The aim of this study was to evaluate the clinical value of myocardial 
contrast DE with MDCT for detecting MVO and LV remodeling revealed by DE-MRI after 
AMI. 
 
Methods 
Study Population 
Between June 2012 and March 2014, 98 consecutive patients with first AMI were initially 
assessed for inclusion into the study. The inclusion criteria for AMI patients were as follows: 
1) chest pain >30 min in duration with presentation within 24 h after onset of symptoms; 2) 
ST-segment elevation >0.1 mV within 2 contiguous electrocardiograph leads; and 3) elevated 
creatine kinase-myocardial band (CK-MB) isoenzymes within 24 h of chest pain. Exclusion 
criteria were a history of previous MI, cardiogenic shock, or renal insufficiency (creatinine 
>1.5 mg/dl). Cardiac rupture caused the death of one patient, re-infarction occurred in one 
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patient due to acute stent thrombosis, cerebrovascular disorder occurred during follow-up in 
two patients, and two patients refused to give their informed consent. Thus, the remaining 92 
patients (77 men and 15 women; mean age, 63±12 years) represent the study population. All 
patients underwent 64-slice MDCT without administration of additional contrast media 
immediately following successful PCI. The study protocol was approved by our institutional 
review board, and all the patients enrolled gave their informed consent. 
 
Sixty-Four-Slice Multidetector Computed Tomography Scanning Procedure 
Scanning was performed using prospective ECG triggering with a 64×0.625 mm slice 
collimation CT scanner (LightSpeed VCT, GE Healthcare, Milwaukee, WI) with a gantry 
rotation speed of 350 ms/rotation. Scanning was performed using a tube energy of 120 kV 
and effective tube current of 200 mA at a table feed of 20 mm/gantry rotation with beam 
pitch of 0.2 and a radiation dose of 2.0 ± 1.0 mSv. Acquisition of CT data and an ECG trace 
were automatically started during a 9- to 12-second breath-hold. Effective radiation doses 
were estimated by multiplying the dose-length product reported by the scanner by a 
conversion factor of 0.014mSv/mGy・cm according to standard methodology outlined in the 
recent guidelines.18  
 
Reconstruction and Analysis of 64-Slice MDCT Images 
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Analysis of the scans was performed on a ZIOSTATION workstation (ZIOSOFT Inc., Tokyo, 
Japan). The original axial CT images and multiplanar reformations were used for analysis of 
the myocardium. The images used for interpretation and for quantitative analysis were 
reconstructed at a slice thickness of 2 mm. Extent of hyperenhancement was judged as 
transmural if ≥75% of the LV wall thickness in each segment of the axial, short-axis, and 
long-axis multiplanar images was visually involved and as subendocardial if <75%. Infarct 
area was defined as a hyperenhancement with signal intensity (SI) greater than 2 standard 
deviations (SD) above the mean SI of remote normal myocardium19 and was adjusted by 
manual tracing of the suspected area in 3 dimensions. Infarct size was calculated on the basis 
of graphics displayed by SI histogram thresholding using a step-based algorithm to detect 
voxels within the defined SI range in the 3 dimensions and to define clusters of voxels that 
meet the hyperenhancement definition. Using this method, the dedicated software determined 
the mean SI of the hyperenhancement in Hounsfield units (HU) and calculated total 
myocardial contrast DE size in grams. We defined heterogeneous enhancement (HE) as the 
concomitant presence of hyper- and hypoenhancement areas within the infarcted myocardium. 
We included both the hypoenhanced area surrounded by the hyperenhanced layer, which is a 
typical finding of MVO on DE-MRI (Figure 1A) and patchy enhancement areas with hyper- 
and hypoenhancement segments (Figure 1B) in heterogeneous enhancement. Figure 1C 
showed no heterogeneous enhancement. The CT density values of the contrast-enhanced 
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myocardium and non-enhanced myocardium in the remote area were measured from at least 
3 regions of interest (ROI) with the dimension of myocardial thickness (Figure 2). Then, to 
normalize the CT values, the relative CT density was calculated as the rate of average density 
of contrast-enhanced myocardium to that of non-enhanced myocardium.15 
 
MRI Protocol 
DE-MRI was performed in the acute phase (median 6 days after AMI onset) and chronic 
phase (median 198 days [median 6 months] after onset). All MRI studies were performed 
with the patient in the supine position in a 1.5-T clinical scanner (MAGNETOM Avanto, 
Siemens, Erlangen, Germany) using a dedicated six-element phase-array cardiac coil. The 
ECG-gated images were acquired during repeated breath-holds of varying duration depending 
on the heart rate. Cine images were obtained using steady-state free-precession cine MRI in 
the two-chamber, four-chamber, and short-axis views. In the cardiac short-axis direction, the 
LV was completely encompassed by contiguous 8-mm-thick slices with a 2-mm interslice gap. 
Next, T2-weighted MRI was performed in the cardiac short-axis direction using a dark-blood 
T2-weighted short-tau inversion-recovery (STIR) fast-spin echo sequence. Finally, 5 to 10 
minutes after injection of 0.2 mmol/kg gadopentetate dimeglumine (Gd-DTPA; Magnevist, 
Bayer, Berlin, Germany), delayed contrast-enhanced images were acquired in the same 
orientation as the cine images using a segmented inversion-recovery gradient-echo pulse 
10 
 
sequence. 
 
MRI Analysis 
Analysis of the scans was performed using Argus viewing software (Siemens). End-diastolic 
volume, end-systolic volume, ejection fraction (EF), and myocardial mass were obtained 
from short-axis cine-MR images. Late gadolinium-enhancement images were assessed both 
for infarct area and MVO area. T2-weighted STIR images were used to determine the 
presence of myocardial hemorrhage in the ischemic myocardium. Infarct area was defined on 
late contrast images as a hyperintense area. Areas of hyperenhancement were defined as 
myocardium with a signal intensity greater than 2 SD above the mean signal intensity of 
remote normal myocardium.19 MVO was defined as a late hypoenhancement signal within 
the myocardial wall surrounded by a hyperenhanced region. Myocardial hemorrhage was 
defined as a hypointense area in the center of the infarct area on T2-weighted images.20 The 
MDCT and MRI images were analyzed by two independent observers to calculate inter- and 
intra-observer agreements. 
 
Coronary Angiography and PCI Procedure 
Experienced interventional cardiologists performed coronary angiography (CAG) through the 
radial or femoral approach with 6-7F catheters. The culprit coronary artery was defined on 
11 
 
the basis of ECG and CAG results. All patients underwent PCI with both aspirin and a 
loading dose of 300 mg clopidogrel. A glycoprotein IIb/IIIa receptor inhibitor is not yet 
available in Japan, so no patient received this drug. 
Before the start of the procedure, 6000-10000 units of heparin were given intravenously, 
and the activated clotting time was maintained at >300 sec. The contrast agent used was 
iopamidol 370 mg I/ml (Schering AG, Berlin, Germany). Post-procedural optimal coronary 
flow was defined as a TIMI flow grade of ≥3, and incomplete reperfusion or lack of 
procedural success was defined as a TIMI flow grade of 0 to 2.21 Time to reperfusion was 
defined as the period from time of onset of symptoms to time of reperfusion. Total contrast 
volume and time from last coronary injection to initiation of the CT scan were also measured. 
 
Study Endpoints 
Study endpoints were defined as the incidence of MVO detected by MRI and the occurrence 
of LV remodeling. LV remodeling was defined as any increase in LV end-systolic volume 
(LVESV) at chronic phase after infarction compared with baseline.20 Study endpoints were 
blinded to the findings of CT imaging. 
Cardiac events were defined as cardiac death, hospitalization for worsening heart failure, 
or sustained ventricular tachycardia / ventricular fibrillation. After hospital discharge, all 
patients were followed up every month at our outpatient clinic of our hospital up to the 6 
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months. Cardiac events were documented by clinical visits, standardized follow-up phone 
calls to the patients or their families, and followed by a review of medical records, 
electrocardiogram, and cardiac enzyme data. To establish the diagnosis of cardiac events, an 
outcome panel of 2 experienced cardiologists reviewed patient data forms containing 
prospectively collected information as well as medical records pertaining to the hospital 
admission.  
 
Statistical Analysis 
All data are expressed as the mean ± SD or median and interquartile range for non-normally 
distributed data. Comparisons of continuous variables were analyzed by unpaired t-test or 
Mann-Whitney U test according to the data distribution. Comparisons of categorical variables 
between groups were performed by the chi-square test without correction for multiplicity. 
Inter- and intraobserver agreements were performed by intraclass correlation coefficients for 
continuous variables and kappa (κ) test for categorical variables. Receiver-operating 
characteristic (ROC) analysis was used to determine optimal cutoff values of relative CT 
density for prediction of MVO. The best cutoff value was defined as the point with the 
highest sum of sensitivity and specificity. The sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV), and diagnostic accuracy of the CT characteristics 
alone or in combination were calculated for prediction of MVO. We performed comparison 
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between 2 groups about various parameters in MVO and LV remodeling respectively, and we 
used the significantly different parameters for the univariable analysis. Multivariable logistic 
regression analysis was then developed to calculate odds ratios and 95% confidence intervals. 
We assessed collinearity for multivariable models by Peason’s correlation and excluded the 
parameters which had collinearity. We performed stepwise forward selection considering any 
valuables with values of P<0.05 to identify potential risk factors for MVO and LV 
remodeling. A P value of <0.05 was considered to indicate statistical significance. 
 
Results 
Patient, Lesion, and Procedural Characteristics 
MVO was detected in 49 (53%) patients and LV remodeling was detected in 29 (32%) 
patients. Patients were divided into 2 groups according to the presence (n=33) or absence 
(n=59) of heterogeneous enhancement detected by MDCT. The median time delay between 
last injection of contrast medium and MDCT scanning was 17±8 min (range 5 to 34 min). 
During the 6-months follow-up periods, 3 cardiac events (1 rehospitalization for worsening 
heart failure and 2 sustained ventricular tachycardia / ventricular fibrillation) were observed 
in HE group, but none in non HE group (P=0.042). Baseline patient characteristics, 
procedural characteristics, and medications are summarized in Table 1. There were no 
statistically significant differences in sex, coronary risk factors, onset to reperfusion time, 
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stent size, stent length, contrast volume, culprit lesion, and TIMI flow between the two 
groups, whereas age was higher in the non HE group. Peak level of CK and its MB fraction 
and BNP level at 7 days were higher in the group with heterogeneous enhancement. Killip 
class 2 or greater heart failure and beta-blocker therapy were more commonly observed in the 
HE group. 
 
MDCT and MRI Measurements 
Representative images from the groups of patients with and without HE are presented in 
Figures 3 and 4. The intra- and inter-observer intraclass correlation coefficients for relative 
CT density were 0.90 (95% CI 0.81-0.95) and 0.89 (95% CI 0.78-0.94), infarct size on 
MDCT were 0.93 (95% CI 0.85-0.96) and 0.94 (95% CI 0.88-0.97), ESV in the acute phase 
were 0.99 (95% CI 0.98-0.99, P<0.001) and 0.97 (95% CI 0.85-0.99), and ESV in the chronic 
phase on MRI were 0.99 (95% CI 0.94-0.99) and 0.99 (95% CI 0.96-0.99), respectively, and 
inter- and intra-observer agreement (κ) for the interpretation of the presence of heterogeneous 
enhancement was 0.91 and 0.81, respectively, and the with all values indicating good intra- 
and inter-observer agreement. CT and MRI findings are summarized in Table 2. The CT 
value of the DE area, relative CT density, transmural enhancement, and myocardial contrast 
DE size were significantly higher in the patients with HE pattern than in those without this 
pattern. On MRI, LVEF was lower, and end-diastolic and end-systolic volumes were 
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significantly larger, in the heterogeneous group. These differences were consistently 
significant in both the acute and chronic phases. The incidences of MVO, myocardial 
hemorrhage, and LV remodeling were significantly more frequent in the heterogeneous 
group. 
 
Predictors of MVO 
According to the ROC analysis, the area under the curve of relative CT density for predicting 
the presence of MVO was 0.889 (95% CI 0.825-0.968). When the cutoff value of 2.20 was 
applied, sensitivity was 86 (95% CI 72.1-94.7)% and specificity was 82 (95% CI 65.7-89.8)%. 
According to the univariable analysis (Table 3), EF <40%, peak CK >4000 IU/ml, the 
presence of heterogeneous enhancement,relative CT density >2.20 and transmural 
enhancement were significantly associated with the presence of MVO. In the multivariable 
logistic regression analysis, the presence of heterogeneous enhancement, relative CT density 
>2.20 and transmural enhancement were significant predictors for the presence of MVO after 
adjustment for multiple confounders. With regard to diagnostic accuracy of CT 
characteristics for predicting MVO, presence of heterogeneous enhancement and relative CT 
density >2.20 showed a high PPV of 93 (95%CI 75.7-99.1) % and absence of these two 
findings yielded a high NPV of 90 (95% CI 76.9-97.3) % for the predictive value of MVO. 
 
16 
 
Predictors of LV Remodeling 
According to the univariable analysis, the presence of heterogeneous enhancement and peak 
CK >4000 and relative CT density were were significantly associated with the occurrence of 
LV remodeling. In the multivariable logistic regression analysis, the presence of 
heterogeneous enhancement was the only significant independent predictor for the occurrence 
of LV remodeling after adjustment for multiple confounders (Table 4). 
 
Discussion 
The major important findings of the study are as follows. First, the presence of heterogeneous 
enhancement and high relative CT density were significant predictors of MVO detected by 
MRI. For prediction of MVO, the presence of both heterogeneous enhancement and high 
relative CT density showed a high PPV of 93%, and their absence offered a high NPV of 90% 
for the detection of MVO. Furthermore, the presence of heterogeneous enhancement was 
significantly associated with adverse LV remodeling in the chronic phase. Thus, in the setting 
of traditional prognostic markers, detection of heterogeneous enhancement on MDCT images 
may provide promising information for prediction of MVO and LV remodeling. 
 
Detection of MVO by MDCT 
The presence of MVO after PCI for AMI corresponds to the angiographic no-reflow 
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phenomenon and is assessed as a hypointense infarct core on late gadolinium enhancement 
by MRI.16 We showed that the presence of heterogeneous enhancement and high relative CT 
density were significant predictors of MVO detected by MRI. A previous report studying 
DE-CT explained that the hyperenhancement area on MDCT is caused by the penetration of 
iodine molecules to the myocardial cells caused by sarcolemmal membrane dysfunction after 
myocyte necrosis, and the hypoenhanced area is caused by the death and subsequent blockage 
of intramyocardial capillaries by cellular debris.9 Another study investigating occlusion, 
microembolization, and reperfusion in an animal model of AMI showed patchy microinfarcts 
and large infarcts with both hyperenhanced and hypoenhanced areas by MDCT. 
Histopathologically, these areas showed patchy microinfarcts adjacent to large infarcts and 
intramyocardial hemorrhage.22 These reports indicate the possibility that heterogeneous 
enhancement is associated with distal embolization and myocardial hemorrhage. In fact, the 
incidence of myocardial hemorrhage was significantly more frequent in the patients with 
heterogeneous enhancement than in those without heterogeneous enhancement in our study. 
Besides, these findings are almost consistent with the findings of MVO. Robbers et al. 
reported that the infarct core of MVO contained extensive necrosis and erythrocyte 
extravasation without intact vasculature, and the surrounding gadolinium-enhanced area of 
MVO contained granulation tissue, leucocyte infiltration, and necrosis with morphologically 
intact microvessels containing microthrombi without erythrocyte extravasation.23 
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The relative CT density was calculated by the average CT values of at least 3 ROIs for 
infarcted and remote areas. It has components of both intensity and transmurality of the 
enhancement. As described above, histopathologically, an area of hyperenhancement 
represents the penetration of iodine molecules into the myocardial cell.9 Therefore, we 
consider that a high relative CT density area reflects the magnitude of myocardial damage 
and might also reflect myocardial hemorrhage. In our study, the patients with MVO and 
myocardial hemorrhage detected by MRI showed significantly higher relative CT density 
than those without (2.67±0.70 vs 1.70±0.58, P<0.001 and 2.81±0.79 vs 1.92±0.63, P<0.001, 
respectively). Histopathologically, hemorrhage is likely to be present in areas of MVO,24 and 
therefore, these finding suggests the possibility that relative CT density is associated with 
myocardial hemorrhage. in that the presence of a low-density area and high relative CT 
density is an important marker for predicting MVO.  
 
Relation between Heterogeneous Enhancement and LV Remodeling 
Heterogeneous enhancement was significantly associated with adverse LV remodeling in the 
chronic phase, indicating the clinical usefulness of myocardial contrast DE. The major 
predictors of adverse LV remodeling in AMI patients are reported to be anterior infarct 
location, peak CK, perfusion status, LVEF, and infarct size.3,4 MVO and myocardial 
hemorrhage are predictors of LV remodeling on MRI.5,17,20 As explained above, 
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heterogeneous enhancement is a significant predictor of MVO, and histopathologically, it has 
the potential to be associated with distal embolization and hemorrhage as with MVO.9,22 
Compared with the patients without heterogeneous enhancement, those with heterogeneous 
enhancement were associated with higher peak CK, larger infarct size, lower LVEF, greater 
numbers of transmural pattern, hemorrhage, and MVO. Therefore, it is natural that 
heterogeneous enhancement should be a predictor of LV remodeling. In addition, previous 
reports have shown that the presence of MVO and/or myocardial hemorrhage is a stronger 
independent predictor of LV remodeling or infarct zone contractile recovery than transmural 
extent of infarction or overall infarct volume.18,24 The present study similarly showed 
heterogeneous enhancement to be an independent predictor of LV remodeling than adjusted 
by transmural extent of infarction or overall infarct volume. 
 
Clinical Implications 
Contrast-enhanced MRI is well established for the assessment of myocardial viability without 
ionizing radiation and injection of nephrotoxic contrast material. However, the facts that 
MDCT can be performed with a short examination times and that it is generally available and 
easily performed are considered important advantages in comparison with contrast-enhanced 
MRI. 
MDCT immediately after PCI provides information on transmurality of infarction, 
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infarct size, and future cardiac events, as does MRI. Furthermore, in this study we showed 
that heterogeneous enhancement detected by MDCT might provide an early predictive 
marker for predicting MVO and LV remodeling in patients with AMI. LV remodeling is an 
important predictor of morbidity and mortality for overt congestive heart failure and 
life-threatening arrhythmias.4 Therefore, if heterogeneous enhancement can be detected with 
MDCT, it would be necessary to plan for prevention of adverse patient outcomes through 
early treatment interventions and careful follow-up. 
 
Study Limitations 
First, because of our relatively small sample size, we acknowledge that our findings should 
be confirmed in a larger number of patients. Second, as the incidence of MVO was high in 
this study, an imbalance between cases and samples might occur in analysis of MVO. Third, 
there is a difference in timing between the DE-MRI and DE-CT examinations. AMI is 
associated with myocardial edema, and therefore, this might also influence the extent of 
myocardial contrast DE. A previous study similarly showed that MRI in the very early days 
after infarction overestimated the true extent of irreversibly injured myocardium because of 
myocardial edema.25 Therefore, it is possible that there is a small difference in the extent of 
DE size and transmurality between DE-MRI and DE-CT. Furthermore, the definition of 
hyperenhancement was not standardized in DE-CT, and so there were the limitations due to a 
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global classification. The definition of optimal threshold for infarct area in DE-CT was also 
not standardized, and therefore standardized analysis using this threshold will further increase 
reproducibility and facilitate (semi) automated quantification. Fourth, the patients receive 
additional radiation exposure from the CT scan after primary PCI. However, we make efforts 
to reduce the radiation exposure by performing low-dose scanning to the extent possible and 
using prospective ECG triggering methods. In doing so, the radiation exposure of the patients 
was reduced to 2.0±1.0 mSv. Furthermore, if we can use a high-specification CT system such 
as a dual-energy scanner or 320-slice MDCT, the better assessment will be provided and the 
radiation exposure will be reduced even further. Finally, the lack of pathological correlation 
might leave the mechanism of these phenomena unclear. Therefore, we consider it necessary 
to investigate the relation between the MDCT images and histopathology and to confirm the 
correspondence between these imaging characteristics and histopathological findings. 
 
Conclusion 
The present study showed that the presence of heterogeneous enhancement on MDCT was 
significantly associated with MVO and LV remodeling in patients with AMI. We consider 
that MDCT images acquired immediately after primary PCI may provide promising 
information for predicting MVO and LV remodeling in patients with AMI. 
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Figure 1. 
 
 
Figure 1. Short-axis DE-CT in 3 patients with acute myocardial infarction. Panels A and B 
show the presence of HE, and Panel C shows no heterogeneous enhancement. Panel A shows 
transmural contrast-delayed enhancement in the anterior wall and a hypoenhanced area 
surrounded by a hyperenhanced layer (arrows), which is a typical finding of microvascular 
obstruction on DE-MRI. Panel B shows transmural contrast-delayed enhancement in the 
lateral wall and a patchy enhancement area with hyper- and hypoenhancement segments 
(arrowheads). Panel C shows subendocardial contrast-delayed enhancement in the inferior 
wall and no HE. DE-CT indicates delayed-enhancement computed tomography; DE-MRI, 
delayed-enhancement magnetic resonance imaging; and HE, heterogenous enhancement. 
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Figure2 
 
 
Figure 2. Short-axis DE-CT of a 49-year-old man. The CT density values of the 
contrast-enhanced myocardium and non-enhanced myocardium were measured from at least 
3 ROIs with the dimension of myocardial thickness. To normalize the CT values, the relative 
CT density was calculated as the rate of average density of contrast-enhanced myocardium to 
that of non-enhanced myocardium. In this image, the relative CT density was calculated to be 
3.18.  
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Figure 3 
 
 
 
Figure 3. A 64-year-old man from the group of patients with heterogeneous enhancement. 
Short-axis DE-CT imaging (A), DE-MRI at 1 week (B), and cine magnetic resonance 
imaging (end-systolic time frame) at 1 week (C), and at 6 months (D). DE-CT imaging (A) 
shows complete transmural contrast-delayed enhancement with heterogeneous enhancement 
(arrows) and high relative CT density. DE-MRI at 1 week (B) shows complete transmural 
enhancement of the left ventricular lateral wall with microvascular obstruction (arrowheads). 
On cine magnetic resonance imaging (C and D), the left ventricular lateral wall was 
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obviously thinned at 6 months. Left ventricular end-systolic volume was increased from 150 
ml at 1 week to 170 ml at 6 months.  
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Figure 4 
 
 
Figure 4. A 64-year-old man from the group without heterogeneous enhancement. Short-axis 
DE-CT imaging (A), DE-MRI at 1 week (B), and cine magnetic resonance imaging 
(end-systolic time frame) at 1 week (C), and at 6 months (D). DE-CT imaging (A) shows 
subendocardial contrast-delayed enhancement without heterogeneous enhancement and with 
low relative CT density. DE-MRI at 1 week (B) shows subendcardial enhancement of the left 
ventricular inferior wall without microvascular obstruction. On cine magnetic resonance 
imaging (C and D), left ventricular end-systolic volume was reduced from 82 ml at 1 week to 
58 ml at 6 months.  
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Table 1.  Baseline Patient Characteristics, Procedural Characteristics, and Medications 
 HE (-) 
n=59 
HE (+) 
n=33 P value 
Age (years) 66±12 58±12 0.002 
Male (%) 81 88 0.416 
Diabetes mellitus (%) 25 33 0.419 
Hypertension (%) 59 67 0.486 
Dyslipidemia (%) 61 73 0.258 
Smoker (%) 51 61 0.367 
BMI 24.6±3.0 25±2.9 0.374 
Laboratory findings 
   
CRP (mg/dl) 0.29±0.38 0.25±0.34 0.596 
LDL (mg/dl) 126±39 131±37 0.409 
Peak CK (IU/ml) 1931±1228 4856±2241 <0.001 
Peak CK-MB (IU/ml) 170±101 398±230 <0.001 
BNP on day 7 (pg/ml) 145±146 227±188 0.042 
Onset-reperfusion time (h) 6.4±6.4 7.4±6.5 0.467 
Stent size (mm) 3.3±0.4 3.3±0.3 0.502 
Stent length (mm) 26.3±7.6 25.0±7.7 0.439 
Contrast volume (ml) 200±58 216±64 0.210 
Culprit lesion: LAD (%) 49 64 0.181 
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            LCx (%) 14 18 0.554 
            RCA (%) 37 18 0.056 
First TIMI flow 0 (%) 53 64 0.303 
Final TIMI flow (0-2) (%) 8 18 0.169 
Killip class ≧2 (%) 3 15 0.041 
Medication after on admission 
   
Aspirin (%) 98 100 0.452 
Clopidogrel (%) 98 100 0.452 
ACE-inhibitor/ARBs (%) 78 88 0.240 
Beta-blockers (%) 73 97 0.004 
Statins (%) 98 100 0.452 
ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BMI, 
body-mass index; BNP, brain natriuretic peptide; CK, creatine kinase; CRP, C-reactive protein; 
HE, heterogeneous enhancement; LAD, left anterior descending artery; and TIMI, Thrombolysis 
in Myocardial Infarction. 
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Table 2.  CT and MRI Findings 
 HE (-) 
n=59 
HE (+) 
n=33 
P value 
CT 
   
CT value: DE area (HU) 94±34 127±28 <0.001 
CT value: remote area (HU) 49±8 48±7 0.287 
Relative CT density 1.9±0.8 2.7±0.6 <0.001 
Transmural enhancement (%) 20 73 <0.001 
Myocardial contrast DE size (g) 9.0±9.2 36.1±17.2 <0.001 
MRI 
   
LVEF baseline (%) 45±9 38±8 0.001 
Chronic phase (%) 49±10 39±8 <0.001 
LVEDV baseline (ml) 119±31 143±38 0.002 
Chronic phase (ml) 110±32 149±40 <0.001 
LVESV baseline (ml) 67±25 90±33 <0.001 
Chronic phase (ml) 56±25 93±34 <0.001 
MVO (%) 31 94 <0.001 
Hemorrhage (%) 19 67 <0.001 
LV remodeling (%) 19 55 <0.001 
CT indicates computed tomography; DE, delayed enhancement; EDV, 
end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; HE, 
heterogeneous enhancement; HU, Hounsfield unit; LV, left ventricular; MRI, 
magnetic resonance imaging; and MVO, microvascular obstruction. 
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Table 3.  Univariable and Multivariable Logistic Regression Analyses for Prediction of MVO 
 Univariable Multivariable (P<0.050) 
Factor OR 95% CI 
P value OR 95% CI 
P value 
Age 0.96 0.93-1.00 0.076    
Sex (male) 1.37 0.45-4.16 0.577    
EF <40% 3.12 1.19-8.14 0.019 1.45 0.33-6.27 0.622 
Peak CK >4000 IU/ml 10.66 2.31-49.12 0.002 0.90 0.08-10.10 0.934 
HE 25.90 5.61-119.48 <0.001 13.50 2.15-84.90 0.005 
Relative CT density >2.2 18.40 5.61-60.00 <0.001 12.00 2.94-49.20 <0.001 
Transmural enhancement 29.56 9.34-93.52 <0.001 6.50 1.32-32.00 0.021 
CI indicates confidence interval; CK, creatine kinase; CT, computed tomography; EF, ejection fraction; 
HE, heterogeneous enhancement; OR, odds ratio; and TIMI, Thrombolysis in Myocardial Infarction. 
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Table 4.  Logistic Regression Analysis for Prediction of LV Remodeling 
Factor 
Univariable Multivariable  (P<0.050) 
OR 95% CI P value OR 95% CI P value 
Age 0.96 0.93-1.00 0.067    
Sex (male) 8.00 0.99-64.10 0.050    
EF <40% 0.57 0.22-1.51 0.264    
Peak CK >4000 IU/ml 3.45 1.32-9.06 0.012 1.44 0.42-4.85 0.561 
HE 5.24 2.03-13.51 <0.001 3.97 1.26-12.60 0.019 
Relative CT density  1.77 1.01-3.12 0.048 1.14 0.57-2.26 0.708 
Myocardial contrast DE size  1.02 0.99-1.05 0.056 
   
Transmural enhancement 2.14 0.874-5.26 0.096    
CI indicates confidence interval; CT, computed tomography; DE, delayed enhancement; EF, ejection 
fraction; HE, heterogeneous enhancement; and OR, odds ratio. 
